At Tynect Biosciences, we are committed to unraveling the complexities of CAR T cell therapy to drive pioneering advancements in the treatment of hematological and solid cancers. Through a multidisciplinary approach, we investigate the intricate interactions of CAR T cells with cancer cells, aiming to decipher the underlying mechanisms of tumor regression and immune response. Utilizing state-of-the-art techniques such as flow cytometry, next-generation sequencing, and single-cell analysis, we delve deep into understanding the dynamics of CAR T cell therapy and its impact on cancer progression and patient outcomes.
Director
Amit Mahajan is an accomplished, serial business entrepreneur with over 14 years of experience in the IT staffing industry. He is President for N Alliance Tech, a leading global digital consultancy. Amit leads daily business operations and directs the development and execution of the company’s global growth strategy and initiatives.
Before starting his own businesses, Amit had gained experience working at Carefirst Blue Cross BlueShield, Washington DC and Department of Treasury at US Bank, Minneapolis. Mr. Mahajan earned a BS in Electronics and Communication Engineering at Punjab Technical University, India. He further did his MS in Electrical Engineering from New Jersey Institute of Technology, USA.
CEO
Ninad has worked as a Project Manager for BNP Paribas on multiple Prime Services, Financing, and Collateral workstreams, focusing on implementing, integrating, and improving processes across Client Executions: Pre-Trade and Post-Trade, Collateral Management, and Regulatory Reporting. He has also worked with Bank of America, Citi Group, and Credit Suisse as a Senior Business Analyst for multiple years.
He has successfully led financial projects throughout their entire lifecycle, from documenting business and functional requirements to successful delivery. He did his MBA (Finance) from the New Jersey Institute of Technology, NJ, and a Bachelors in Mechanical Engineering from Sardar Patel University, India.
CEO
Ninad has worked as a Project Manager for BNP Paribas on multiple Prime Services, Financing, and Collateral workstreams, focusing on implementing, integrating, and improving processes across Client Executions: Pre-Trade and Post-Trade, Collateral Management, and Regulatory Reporting. He has also worked with Bank of America, Citi Group, and Credit Suisse as a Senior Business Analyst for multiple years.
He has successfully led financial projects throughout their entire lifecycle, from documenting business and functional requirements to successful delivery. He did his MBA (Finance) from the New Jersey Institute of Technology, NJ, and a Bachelors in Mechanical Engineering from Sardar Patel University, India.
Principal R&D Scientist
Dr. Anuj is a Molecular cell biologist with 8+ years of experience in; molecular and cell biology, recombination protein purification, and in vitro/ex vivo assay. He has expertise in the development of biophysical and cellular assays for cell signaling, protein trafficking, and Human parasite
He was a Post Doctorate Research Associate with Meharry Medical College in Nashville, Tennessee, and was a Research Associate and fellow with the National Institute of Immunology (NII), New Delhi & Central Drug Research Institute, Lucknow India respectively. He also holds Ph.D. in Drug development and molecular biology Malaria.
Senior Scientist
Dr. Kumar has demonstrated adaptability in incorporating microbiology, molecular biology, cell biology, and immunology to address complex biological challenges, leading to a deeper understanding of cellular processes and host-pathogen interactions. He has contributed to various scientific journals, addressing areas from nanoparticle development for sepsis treatment to plant tissue culture methods, highlighting a diverse and adaptable research profile.
Proficient in a broad array of research techniques, from molecular biology (e.g., PCR, qRT-PCR, Western blotting) to microbiology and plant tissue culture, ensuring flexibility in various life science research settings. He holds a Ph.D. in In Dept. of Biochemistry and Microbial Sciences from Central University of Punjab, Bathinda, India, and a Master of Philosophy in Biosciences from the same.
Senior Scientist
Dr. Kumar has demonstrated adaptability in incorporating microbiology, molecular biology, cell biology, and immunology to address complex biological challenges, leading to a deeper understanding of cellular processes and host-pathogen interactions. He has contributed to various scientific journals, addressing areas from nanoparticle development for sepsis treatment to plant tissue culture methods, highlighting a diverse and adaptable research profile.
Proficient in a broad array of research techniques, from molecular biology (e.g., PCR, qRT-PCR, Western blotting) to microbiology and plant tissue culture, ensuring flexibility in various life science research settings. He holds a Ph.D. in In Dept. of Biochemistry and Microbial Sciences from Central University of Punjab, Bathinda, India, and a Master of Philosophy in Biosciences from the same.
